Syntax Research »

Amgen shares owned by Syntax Research

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Syntax Research from 13F filings

Historical chart of Syntax Research investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Syntax Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Syntax Research

Quarter filed Position value Share count Share price at filing
2024-03-31 $67k 237 284.32
2023-12-31 $68k 237 288.02

More positions owned by Syntax Research

Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Usa Value (VLUE)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Proshares Tr S&p 500 Dv Arist (NOBL)
Ishares Tr Msci Acwi Ex Us (ACWX)
Ishares Tr Core Msci Euro (IEUR)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Qualcomm (QCOM)
Air Products & Chemicals (APD)
Nutrien (NTR)
Newmont Mining Corporation (NEM)
American Tower Reit (AMT)

View all positions for Syntax Research

Top funds holding Amgen

Vanguard Group
BlackRock
PRIMECAP Management Company
Morgan Stanley
Geode Capital Management
Charles Schwab Investment Management
Wells Fargo & Company
Northern Trust
Royal Bank of Canada
Bank of New York Mellon
Barclays
Legal & General Group
Goldman Sachs Group
Reed Conner & Birdwell
FMR

View all funds holding Amgen